Breast cancer - management of resistant disease: papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Oxford [u.a]
Pergamon
1995
|
| Schriftenreihe: | [European journal of cancer / A / Supplement]
31,7 |
| Schlagworte: | |
| Beschreibung: | 24 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010515955 | ||
| 003 | DE-604 | ||
| 005 | 19961025 | ||
| 007 | t | ||
| 008 | 951207s1995 |||| 10||| eng d | ||
| 035 | |a (OCoLC)69002999 | ||
| 035 | |a (DE-599)BVBBV010515955 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-29 |a DE-12 |a DE-20 | ||
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 084 | |a XH 8450 |0 (DE-625)152958:13129 |2 rvk | ||
| 245 | 1 | 0 | |a Breast cancer - management of resistant disease |b papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| 264 | 1 | |a Oxford [u.a] |b Pergamon |c 1995 | |
| 300 | |a 24 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a [European journal of cancer / A / Supplement] |v 31,7 | |
| 650 | 7 | |a Borstkanker |2 gtt | |
| 650 | 0 | 7 | |a Therapieresistenz |0 (DE-588)4133317-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1994 |z Amsterdam |2 gnd-content | |
| 655 | 7 | |a Congressen (vorm) |2 gtt | |
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 0 | 2 | |a Therapieresistenz |0 (DE-588)4133317-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 2 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 710 | 2 | |a European School of Oncology |e Sonstige |0 (DE-588)2087039-5 |4 oth | |
| 810 | 2 | |a A / Supplement] |t [European journal of cancer |v 31,7 |w (DE-604)BV008922295 |9 31,7 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007009482 | ||
Datensatz im Suchindex
| _version_ | 1804124983074488320 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV010515955 |
| classification_rvk | XH 3200 XH 8450 |
| ctrlnum | (OCoLC)69002999 (DE-599)BVBBV010515955 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01977nam a2200493 cb4500</leader><controlfield tag="001">BV010515955</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19961025 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">951207s1995 |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)69002999</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010515955</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 8450</subfield><subfield code="0">(DE-625)152958:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Breast cancer - management of resistant disease</subfield><subfield code="b">papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford [u.a]</subfield><subfield code="b">Pergamon</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">24 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">[European journal of cancer / A / Supplement]</subfield><subfield code="v">31,7</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Borstkanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Amsterdam</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Congressen (vorm)</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">European School of Oncology</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2087039-5</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">A / Supplement]</subfield><subfield code="t">[European journal of cancer</subfield><subfield code="v">31,7</subfield><subfield code="w">(DE-604)BV008922295</subfield><subfield code="9">31,7</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007009482</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1994 Amsterdam gnd-content Congressen (vorm) gtt |
| genre_facet | Konferenzschrift 1994 Amsterdam Congressen (vorm) |
| id | DE-604.BV010515955 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:54:19Z |
| institution | BVB |
| institution_GND | (DE-588)2087039-5 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007009482 |
| oclc_num | 69002999 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29 DE-12 DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-29 DE-12 DE-20 |
| physical | 24 S. |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Pergamon |
| record_format | marc |
| series2 | [European journal of cancer / A / Supplement] |
| spelling | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands Oxford [u.a] Pergamon 1995 24 S. txt rdacontent n rdamedia nc rdacarrier [European journal of cancer / A / Supplement] 31,7 Borstkanker gtt Therapieresistenz (DE-588)4133317-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1994 Amsterdam gnd-content Congressen (vorm) gtt Brustkrebs (DE-588)4008528-4 s Chemotherapie (DE-588)4127083-6 s Therapieresistenz (DE-588)4133317-2 s DE-604 Krebs Medizin (DE-588)4073781-0 s Cytostatikum (DE-588)4068347-3 s Arzneimittelresistenz (DE-588)4143180-7 s European School of Oncology Sonstige (DE-588)2087039-5 oth A / Supplement] [European journal of cancer 31,7 (DE-604)BV008922295 31,7 |
| spellingShingle | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands Borstkanker gtt Therapieresistenz (DE-588)4133317-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Brustkrebs (DE-588)4008528-4 gnd Chemotherapie (DE-588)4127083-6 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd |
| subject_GND | (DE-588)4133317-2 (DE-588)4073781-0 (DE-588)4008528-4 (DE-588)4127083-6 (DE-588)4143180-7 (DE-588)4068347-3 (DE-588)1071861417 |
| title | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_auth | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_exact_search | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_full | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_fullStr | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_full_unstemmed | Breast cancer - management of resistant disease papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| title_short | Breast cancer - management of resistant disease |
| title_sort | breast cancer management of resistant disease papers from a european school of oncology task force workshop 6 september 1994 amsterdam the netherlands |
| title_sub | papers from a European School of Oncology task force workshop ; 6 September 1994, Amsterdam, The Netherlands |
| topic | Borstkanker gtt Therapieresistenz (DE-588)4133317-2 gnd Krebs Medizin (DE-588)4073781-0 gnd Brustkrebs (DE-588)4008528-4 gnd Chemotherapie (DE-588)4127083-6 gnd Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd |
| topic_facet | Borstkanker Therapieresistenz Krebs Medizin Brustkrebs Chemotherapie Arzneimittelresistenz Cytostatikum Konferenzschrift 1994 Amsterdam Congressen (vorm) |
| volume_link | (DE-604)BV008922295 |
| work_keys_str_mv | AT europeanschoolofoncology breastcancermanagementofresistantdiseasepapersfromaeuropeanschoolofoncologytaskforceworkshop6september1994amsterdamthenetherlands |